Clinical Trials Directory

Trials / Unknown

UnknownNCT04179435

Cognitive and Brain Development in Adolescents With Gilles de la Tourette Syndrome

Développement Cognitif et cérébral Chez Les Adolescents Souffrants d'un Syndrome de Gilles de la Tourette

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
132 (estimated)
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France · Other Government
Sex
All
Age
13 Years – 18 Years
Healthy volunteers
Accepted

Summary

In children with neurodevelopmental disorders, adolescence is usually associated with a reshaping of the clinical picture and symptomatology. Tourette syndrome (TS) is a paradigmal neurodevelopmental syndrome characterised by involuntary paroxysmal movements (motor tics) and vocalisation (vocal tics) often associated with various psychiatric disorders. The neuronal and cognitive mechanisms associated with TS symptoms improvement during adolescence, or the persistence in adulthood remains unknown, and this is what we aim to address in this study.

Detailed description

Thus, the aims of the present project is threefold: Aim 1: To evaluate the maturation of cognitive functions in adolescents with TS compared to typically developing adolescents. To achieve this aim, three distinct cognitive dimensions will be assessed in all subjects (patients and controls): (i) reward sensitivity and habit formation; (ii) cognitive impulsivity and action control and (iii) self-agency. Aim 2: To identify neuronal correlates of cognitive function and brain development in health and disease. To achieve this aim, we will use a combined behavioural (as described in Aim 1), (i) neuroimaging and (ii) TMS approaches. Aim 3: To predict clinical outcome . In this part of the project we aim to identify behavioural, imaging or neurophysiological markers of clinical outcome in patients with TS.

Conditions

Interventions

TypeNameDescription
BEHAVIORALBehavioral testing on cognitive computerized tasksTesting on cognitive computerized tasks
OTHERbrain MRIBrain MRI scans
OTHERTMSMeasure of the cortical inhibitory capacity using TMS measures

Timeline

Start date
2019-12-01
Primary completion
2021-12-01
Completion
2023-12-01
First posted
2019-11-27
Last updated
2019-11-27

Source: ClinicalTrials.gov record NCT04179435. Inclusion in this directory is not an endorsement.